Active ingredients: budesonide
What it is used for
Treatment of bronchial asthma and long term prophylaxis. INDICATIONS AS APPROVED 15 JULY 1997: Treatment of bronchial asthma. Pulmicort may also be used when replacement or reduction in oral steroid therapy is desirable. Treatment of acute laryngotracheobronchitis (croup) in infants and children.
How to take it
The way to take this medicine is: Inhalation.
- Store below 30 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
An easily resuspendable white to off-white suspension.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient budesonide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems